Evidence map›Paper›PMID 23661677›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2013

Mineralocorticoid receptor agonists induce mouse aortic aneurysm formation and rupture in the presence of high salt.

Shu Liu, Zhongwen Xie, Alan Daugherty, Lisa A Cassis, Kevin J Pearson, Ming C Gong, Zhenheng Guo

Open access · bronzeAbstract read
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it, 82 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Unleashing PD-1: a duel of immunity in aortic aneurysm formation.The Journal of clinical investigation · 2024
    Article
  10. Article
  11. Review
  12. Observational
  13. Article
  14. The mechanism and therapy of aortic aneurysms.Signal transduction and targeted therapy · 2023
    Review
  15. Article
  16. Review
  17. Development of pharmacotherapies for abdominal aortic aneurysms.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2022
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Shu LiuDepartment of Internal Medicine, University of Kentucky, Lexington, KY 40536, USA.
Zhongwen Xie
Alan Daugherty
Lisa A Cassis
Kevin J Pearson
Ming C Gong
Zhenheng Guo
University of Kentucky · US

Funding

YOGA LIFESTYLE INTERVENTION REDUCES BLOOD PRESSURE IN HIV-INFECTED ADULTSP41RR000954 · NCRR · WASHINGTON UNIVERSITY · PI GROSS, MICHAEL L · 1985 to 2011
$16.0M
The role of IKKß in linking obesity to adipose tissue inflammation and adipogeneP20GM103527 · NIGMS · UNIVERSITY OF KENTUCKY · PI CASSIS, LISA A · 2012 to 2017
$13.7M
TrainingP41GM103422 · NIGMS · WASHINGTON UNIVERSITY · PI YARASHESKI, KEVIN E · 2012 to 2019
$12.0M
Sex Differences in Angiotensin-Induced Vascular DiseasesR01HL107326 · NHLBI · UNIVERSITY OF KENTUCKY · PI CASSIS, LISA A · 2012 to 2019
$3.7M
A Biomedical Mass Spectrometry Resource: Ongoing Driving Biomedical ProjectsR24GM136766 · NIGMS · WASHINGTON UNIVERSITY · PI GROSS, MICHAEL L · 2020 to 2022
$2.3M
A Novel Mechanism by which iPLA2 Links Diabetes to Cardiovascular DiseasesR01HL088389 · NHLBI · UNIVERSITY OF KENTUCKY · PI GUO, ZHENHENG · 2008 to 2012
$2.1M
Regulation of Blood Pressure Circadian Rhythm by Vascular Smooth Muscle BMAL1R01HL106843 · NHLBI · UNIVERSITY OF KENTUCKY · PI GONG, MING C, GUO, ZHENHENG · 2012 to 2015
$2.0M
Vascular Smooth Muscle Hyper-contractility/HypertensionR01HL082791 · NHLBI · UNIVERSITY OF KENTUCKY · PI GONG, MING C · 2006 to 2010
$1.6M
NCRR NIH HHS P41 RR000954NHLBI NIH HHS HL082791NHLBI NIH HHS HL088389NHLBI NIH HHS HL088389-02S1NHLBI NIH HHS HL106843NHLBI NIH HHS R01 HL082791NHLBI NIH HHS R01 HL088389NHLBI NIH HHS R01 HL106843NHLBI NIH HHS R01 HL107326NIGMS NIH HHS 8 P20 GM103527-05NIGMS NIH HHS P20 GM103527NIGMS NIH HHS P41 GM103422NIGMS NIH HHS R24 GM136766
6 · The paper itself

Abstract

objectiveElevated plasma aldosterone concentrations in patients have been linked to a spectrum of cardiovascular diseases. Mineralocorticoid receptor antagonists provide additional benefits in patients with heart failure. However, whether aldosterone and the mineralocorticoid receptor are involved in aortic aneurysm is unknown. APPROACH AND

resultsWe report that administration of deoxycorticosterone acetate (DOCA) and salt or aldosterone and salt, but not DOCA or salt alone, to C57BL/6 male mice induced abdominal and thoracic aortic aneurysm formation and rupture in an age-dependent manner. DOCA and salt- or aldosterone and salt-induced aortic aneurysm mimicked human aortic aneurysm with respect to elastin degradation, inflammatory cell infiltration, smooth muscle cell degeneration and apoptosis, and oxidative stress. Aortic aneurysm formation did not correlate with the increase in blood pressure induced by DOCA and salt. Systemic administration of the angiotensin-converting enzyme inhibitor, enalapril, or angiotensin type 1 receptor antagonist, losartan, did not affect DOCA and salt-induced aortic aneurysm. In contrast, the mineralocorticoid receptor antagonists, spironolactone or eplerenone, significantly attenuated DOCA and salt- or aldosterone and salt-induced aortic aneurysm.

conclusionsThe current study describes a novel aortic aneurysm animal model induced by mineralocorticoid receptor agonist and high salt, and reveals a previously unrecognized but potentially significant role of aldosterone in the pathogenesis of aortic aneurysm. These findings imply that mineralocorticoid receptor antagonists may be effective in the treatment of some aortic aneurysms.

Indexed as

DesoxycorticosteroneSodium Chloride, DietaryAldosteroneAngiotensin-Converting Enzyme InhibitorsAngiotensin II Type 1 Receptor BlockersAnimalsAortaAortic Aneurysm, AbdominalAortic Aneurysm, ThoracicAortic RuptureApoptosisBlood PressureDisease Models, AnimalElastinEnalaprilEplerenoneAldosteroneAngiotensin-Converting Enzyme InhibitorsAngiotensin II Type 1 Receptor BlockersDesoxycorticosteroneElastinEnalaprilEplerenoneLosartanMineralocorticoid Receptor AntagonistsReceptors, MineralocorticoidSodium Chloride, DietarySpironolactonealdosteroneaneurysmdesoxycorticosteronereceptorssalt

Identifiers

PMID23661677
PMCPMC3707291
OpenAlexW2096488529

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.